Qualigen Therapeutics, Inc.
A clinical-stage company developing innovative treatments for rare cancers in adults and children.
QLGN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74754R1032 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 2042 CORTE DEL NOGAL, 92011 CALIFORNIA
- Website:
- https://qlgntx.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company dedicated to developing innovative treatments for adult and pediatric patients with cancer. The company focuses on areas of high unmet medical need, particularly rare cancers. Its development pipeline features several investigational oncology programs, including QN-302, Pan-RAS, and QN-247. Qualigen's approach involves combining its development and commercialization capabilities with expertise from major cancer research institutions to advance its therapeutic candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Qualigen Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Qualigen Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Qualigen Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
